Zurzuvae Prices at US Pharmacies

Our most recent US pharmacy data shows a low of roughly $17,330.54 for Zurzuvae with a standard discount card. That figure moves with dosage and quantity — check the comparison table for the exact combination you need.

Generic and brand-name pricing for Zurzuvae is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.

Coverage and cost-sharing for Zurzuvae under private insurance plans vary significantly based on the specific formulary and plan design. You should contact your insurance provider to confirm whether Zurzuvae is covered and to learn your exact copay or coinsurance amount. If your plan does not cover the medication, or if your out-of-pocket cost is high, exploring patient assistance programs or pharmacy savings options may provide an alternative path to lower costs.

Coverage under Medicare Part D or Medicare Advantage plans is not guaranteed and depends on the individual plan's formulary. If covered, your cost will depend on your plan's benefit phase (e.g., deductible, initial coverage, coverage gap). You should review your plan's drug list or contact your plan administrator for details. If Zurzuvae is not covered or you have a high deductible, the full retail price may apply. In such cases, investigating other savings options, such as manufacturer coupons or patient assistance programs, may help lower your expense.

Zurzuvae (zuranolone) is a brand-name medication developed by Sage Therapeutics and Biogen. A generic, or bioequivalent, version is not currently available in the United States. As a newer medication, it is protected by patents, so a generic alternative is not expected for several years.